These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 1690924)

  • 1. Binding of (chloroethyl 3H) cyclophosphamide to rat embryo proteins: two-dimensional gel analysis.
    Mirkes PE; Little SA
    Teratology; 1990 Feb; 41(2):195-204. PubMed ID: 1690924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
    Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL
    Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake and binding of tritium from [chloroethyl 3H] cyclophosphamide by rat embryos in vitro.
    Mirkes PE; Greenaway JC
    Teratology; 1985 Jun; 31(3):373-80. PubMed ID: 4012646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The problem of oncostatic specificity of cyclophosphamide (NSC-26271): Studies on reactions that control the alkylating and cytotoxic activity.
    Hohorst HJ; Draeger U; Peter G; Voelcker G
    Cancer Treat Rep; 1976 Apr; 60(4):309-15. PubMed ID: 1277206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkylation of prohibitin by cyclohexylphenyl-chloroethyl urea on an aspartyl residue is associated with cell cycle G(1) arrest in B16 cells.
    Bouchon B; Papon J; Communal Y; Madelmont JC; Degoul F
    Br J Pharmacol; 2007 Oct; 152(4):449-55. PubMed ID: 17704829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microtubule disruption induced in vivo by alkylation of beta-tubulin by 1-aryl-3-(2-chloroethyl)ureas, a novel class of soft alkylating agents.
    Legault J; Gaulin JF; Mounetou E; Bolduc S; Lacroix J; Poyet P; Gaudreault RC
    Cancer Res; 2000 Feb; 60(4):985-92. PubMed ID: 10706114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic cyclophosphamide exposure alters the profile of rat sperm nuclear matrix proteins.
    Codrington AM; Hales BF; Robaire B
    Biol Reprod; 2007 Aug; 77(2):303-11. PubMed ID: 17475930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and pharmacokinetics of cyclophosphamide (NSC-26271) metabolites in vivo.
    Voelcker G; Wagner T; Hohorst HJ
    Cancer Treat Rep; 1976 Apr; 60(4):415-22. PubMed ID: 1277216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of alkylated proteins in the monitoring of exposure to alkylating agents.
    Farmer PB; Bailey E; Campbell JB
    IARC Sci Publ; 1984; (59):189-98. PubMed ID: 6545280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in DNA alkylation products formed in sensitive and resistant human glioma cells treated with N-(2-chloroethyl)-N-nitrosourea.
    Bodell WJ; Tokuda K; Ludlum DB
    Cancer Res; 1988 Aug; 48(16):4489-92. PubMed ID: 3396000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dosage, phenobarbital, and 2-diethylaminoethyl-2,2-diphenylvalerate on the binding of cyclophosphamide and-or its metabolites to the DNA, RNA, and protein of the embryo and liver in pregnant mice.
    Murthy VV; Becker BA; Steele WJ
    Cancer Res; 1973 Apr; 33(4):664-70. PubMed ID: 4696467
    [No Abstract]   [Full Text] [Related]  

  • 12. The binding of beta-propiolactone and some related alkylating agents to DNA, RNA, and protein of mouse skin; relation between tumor-initiating power of alkylating agents and their binding to DNA.
    Colburn NH; Boutwell RK
    Cancer Res; 1968 Apr; 28(4):653-60. PubMed ID: 5649056
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
    Crook TR; Souhami RL; McLean AE
    Cancer Res; 1986 Oct; 46(10):5029-34. PubMed ID: 3463409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage in cyclophosphamide-resistant tumor cells: the role of glutathione.
    Richardson ME; Siemann DW
    Cancer Res; 1995 Apr; 55(8):1691-5. PubMed ID: 7712476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nature of the binding of activated cyclophosphamide to calf thymus DNA and pBR-322 plasmid DNA.
    Bansal SK; Love JH; Faletto MB; Gurtoo HL; Struck RF
    Cancer Biochem Biophys; 1986 Jul; 8(3):193-202. PubMed ID: 3742481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-(2-hydroxyethyl)-N-[2-(7-guaninyl)ethyl]amine, the putative major DNA adduct of cyclophosphamide in vitro and in vivo in the rat.
    Benson AJ; Martin CN; Garner RC
    Biochem Pharmacol; 1988 Aug; 37(15):2979-85. PubMed ID: 3395373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of DNA damage and embryotoxicity induced by 4-hydroperoxydechlorocyclophosphamide in postimplantation rat embryos.
    Little SA; Mirkes PE
    Teratology; 1990 Feb; 41(2):223-31. PubMed ID: 2321166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide.
    Gurtoo HL; Hipkens JH; Sharma SD
    Cancer Res; 1981 Sep; 41(9 Pt 1):3584-91. PubMed ID: 7260917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein expression in the tissues of the cardiovascular system of the rat under selenium deficiency and adequate conditions.
    Kyriakopoulos A; Richter A; Pohl T; Wolf C; Grbavac I; Plotnikov A; Kühbacher M; Bertelsmann H; Behne D
    Ann N Y Acad Sci; 2007 Jan; 1095():300-4. PubMed ID: 17404042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential transactivation of human metallothionein-IIa in cisplatin-resistant and -sensitive cells.
    Yang YY; Robbins PD; Lazo JS
    Oncol Res; 1998; 10(2):85-98. PubMed ID: 9666516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.